US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
기사승인 2018.10.11 12:10:11
Lee Han-soo corea022@docdocdoc.co.kr
- 1PharmaKainos Medicine starts developing treatment for multiple system atrophy
- 2PharmaAbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs
- 3PharmaPfizer feeling bittersweet over Korea’s biosimilars
- 4Device/ICTRegulators raid Abbott Korea over rebate allegations
- 5PharmaSanofi gets nod to increase dosage for multiple sclerosis treatment
- 6Life scienceDirect-acting antivirals reduce death risk for hepatitis C patients: study
- 7Life scienceKUGH uses big data-based machine learning to predict type 2 diabetes
set_C1
